Value proposition

First clinically validated mobile app for intelligent insulin dosing.

DiappyMed is a French start-up specialized in the development of mobile applications for personalizing T1 and T2 diabetes treatment.

Our mission is to create a user-friendly tools with proven clinical performance, easily accessible to support everyone with diabetes towards a better glycemic control and more freedom in daily life.

Designed with over 2,000 patients and a medical committee, based on data science and artificial intelligence technologies, our all-in-one solutions are:
- EkiYou Carbs, which provides carbohydrates counting.
- EkiYou, a CE-marked medical device (1912) which provides personalized insulin dose recommendation.

Our first clinical trials show an improvement of patient’s blood glucose level control (time in range).